Reaction
Gastrectomy reporting signals
As of the last recalculation, Gastrectomy appears in 1,000 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is IMATINIB MESYLATE (PRR 22.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Imatinib Mesylate | 29 | 22.3 | 22.3 |
| Pancrelipase | 39 | 21.8 | 21.9 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 5 | 10.4 | 10.4 |
| Avapritinib | 6 | 10.4 | 10.4 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 9.7 | 9.7 |
| Dolutegravir Sodium | 4 | 9.3 | 9.3 |
| Sodium Oxybate | 26 | 8.4 | 8.4 |
| Risankizumab-Rzaa | 30 | 7.8 | 7.8 |
| Dimethyl Fumarate | 32 | 5.6 | 5.6 |
| Etonogestrel | 8 | 3.5 | 3.5 |
| Cinacalcet Hydrochloride | 6 | 2.7 | 2.7 |